Methods for assessing HIV and HIV risk among IDUs and for evaluating interventions

Abstract A wide range of methods is now available for assessing the nature and characteristics of drug injecting populations, and for evaluating the effectiveness of interventions developed to reduce injecting related harms. The public health surveillance tasks in relation to injecting drug use populations and associated health problems are the same, in principle, as for the surveillance of other health problems. These are: to describe the patterns of the condition, the nature of the problem and the environment (context) in which it occurs; to determine the scale of interventions needed and estimated coverage required, to forecast future health care needs; to mobilise resources and target prevention; and to evaluate interventions. Countries vary in their existing levels of information as well as resources for surveillance systems, research and evaluation. We propose three levels of assessment: basic assessment, which is suitable in situations of low awareness and information, routine surveillance, and enhanced surveillance, which requires more complex research and/or analyses of data collected from routine surveillance.

[1]  Frances Sharp,et al.  Modelling drug use: methods to quantify and understand hidden processes. , 2001 .

[2]  P. Bourgois,et al.  Social misery and the sanctions of substance abuse : Confronting HIV risk among homeless heroin addicts in San Francisco , 1997 .

[3]  Ronald E. LaPorte,et al.  Capture-recapture and multiple-record systems estimation I: History and theoretical development ( Review ) , 1995 .

[4]  R. Dwyer,et al.  For love or money? An exploratory study of why injecting drug users participate in research. , 2001, Addiction.

[5]  L. Degenhardt,et al.  Estimating the prevalence of problematic drug use: a review of methods and their application , 2002 .

[6]  H. Ward,et al.  Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control , 1997, The Lancet.

[7]  T. Rhodes,et al.  AIDS, drugs and prevention : perspectives on individual and community action , 1996 .

[8]  R. Booth,et al.  Issues and Approaches to Evaluating HIV Outreach Interventions , 1996 .

[9]  S. Friedman,et al.  Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. , 2000, American journal of public health.

[10]  M. Hickman,et al.  Over a decade of syringe exchange: results from 1997 UK survey. , 2002, Addiction.

[11]  A. Ades Serial HIV seroprevalence surveys: interpretation, design, and role in HIV/AIDS prediction. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[12]  G. Stimson AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic. , 1995, Social science & medicine.

[13]  K. Tilling,et al.  Capture-recapture models including covariate effects. , 1999, American journal of epidemiology.

[14]  S B Thacker,et al.  Public health surveillance in the United States. , 1988, Epidemiologic reviews.

[15]  N. Walker,et al.  Epidemiological analysis of the quality of HIV sero-surveillance in the world: how well do we track the epidemic? , 2001, AIDS.

[16]  Nicholas C. Grassly,et al.  Modelling emerging HIV epidemics: the role of injecting drug use and sexual transmission in the Russian Federation, China and India , 2003 .

[17]  E H Kaplan,et al.  Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. , 1989, Reviews of infectious diseases.

[18]  Mark W. Lipsey,et al.  Evaluation: A Systematic Approach , 1979 .

[19]  D. Shanson,et al.  Changes in recommendations about amoxycillin prophylaxis for prevention of endocarditis , 1997, The Lancet.

[20]  D. Vlahov,et al.  Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. , 2003, American journal of epidemiology.

[21]  C. Watts,et al.  The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. , 2004, Addiction.

[22]  R. Laranjeira,et al.  HIV-risk behaviour among non-heroin using cocaine injectors and non-injectors in São Paulo, Brazil , 2000, AIDS care.

[23]  M. Ramanathan,et al.  Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes , 2000, AIDS.

[24]  R J Mills,et al.  Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. , 1998, Public health reports.

[25]  D. D. Des Jarlais,et al.  Maintaining low HIV seroprevalence in populations of injecting drug users. , 1995, JAMA.

[26]  E. V. van Ameijden,et al.  Maximum impact of HIV prevention measures targeted at injecting drug users , 1998, AIDS.

[27]  C. Watts,et al.  The impact of an HIV prevention intervention for injecting drug users in Svetlogorsk, Belarus: model predictions , 2002 .

[28]  S. Friedman,et al.  Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health? , 1999, Addiction.

[29]  M. Martínez de Pancorbo,et al.  The validation of statements by IDUs based on the analysis of blood traces on their used syringes. , 1998, AIDS care.

[30]  Guidelines for second generation HIV Surveillance , 2000 .

[31]  W. Hall,et al.  Back-projection estimates of the number of dependent heroin users in Australia. , 2001, Addiction.

[32]  S. Darke,et al.  Self-report among injecting drug users: a review. , 1998, Drug and alcohol dependence.

[33]  F. Lert,et al.  Unsafe injecting practices among attendees of syringe exchange programmes in France. , 2001, Addiction.

[34]  Stimson Gv Reconstruction of subregional diffusion of HIV infection among injecting drug users in Southeast Asia: implications for early intervention. , 1994 .

[35]  J. Parry,et al.  HIV‐1 prevalence in community‐wide samples of injecting drug users in London, 1990–1993 , 1996, AIDS (London).

[36]  T. Rhodes,et al.  SEX-RAR guide: the rapid assessment and response guide on psychoactive substance use and sexual risk behaviour. , 2002 .

[37]  R. Laranjeira,et al.  Genetic Diversity and HIV‐1 Incidence Estimation Among Cocaine Users in São Paulo, Brazil , 2002, Journal of acquired immune deficiency syndromes.

[38]  J. Grund,et al.  Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. , 1992, British journal of addiction.

[39]  M. Schechter,et al.  Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. , 1999, AIDS.

[40]  Mitchell H. Gail,et al.  AIDS Epidemiology: A Quantitative Approach , 1994 .

[41]  S. Lai,et al.  REAWAKENING THE DRAGON: CHANGING PATTERNS OF OPIATE USE IN ASIA, WITH PARTICULAR EMPHASIS ON CHINA'S YUNNAN PROVINCE , 2001, Substance use & misuse.

[42]  R. Detels,et al.  Characteristics of risk-taking behaviors, HIV and AIDS knowledge, and risk perception among young males in southwest China. , 1997, AIDS education and prevention : official publication of the International Society for AIDS Education.

[43]  Habibur Rahman,et al.  Measuring the impact of needle exchange programs among injecting drug users through the National Behavioural Surveillance in Bangladesh. , 2001, AIDS education and prevention : official publication of the International Society for AIDS Education.

[44]  Jie Chen,et al.  Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia , 2000, AIDS.

[45]  Tim Brown,et al.  Potential impact of HIV among IDUs on heterosexual transmission in Asian settings: scenarios from the Asian Epidemic Model , 2003 .

[46]  A. Rodger,et al.  A certain fate: Spread of HIV among young injecting drug users in Manipur, North-East India , 2000, AIDS care.

[47]  Douglas D. Heckathorn,et al.  Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .

[48]  D. D. Des Jarlais,et al.  HIV surveillance among injecting drug users. , 2001, AIDS.

[49]  T. Brown,et al.  Meeting the behavioural data collection needs of national HIV / AIDS and STD programmes. A joint IMPACT / FHI / UNAIDS workshop: report and conclusions. , 1998 .

[50]  G. Stimson,et al.  Drug injecting and HIV infection : global dimensions and local responses , 1998 .

[51]  G. Garnett The basic reproductive rate of infection and the course of HIV epidemics. , 1998, AIDS patient care and STDs.

[52]  C. Archibald,et al.  A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. , 1998, AIDS care.

[53]  S. Friedman,et al.  Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. , 1994, JAMA.

[54]  J. Notenboom,et al.  Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users. , 1999, Addiction.

[55]  F. Bastos,et al.  [Social networks and diffusion of AIDS in Brazil]. , 1996, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.

[56]  Matthew Hickman,et al.  Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia , 2002, AIDS.

[57]  L. Ouellet,et al.  Shooting Galleries and HIV Disease: Variations in Places for Injecting Illicit Drugs , 1991 .

[58]  E H Kaplan,et al.  HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange. , 1992, Journal of acquired immune deficiency syndromes.

[59]  G. Stimson,et al.  A short questionnaire (IRQ) to assess injecting risk behaviour. , 1998, Addiction.

[60]  S. Hutchinson,et al.  High risk injecting behaviour among injectors from Glasgow: cross sectional community wide surveys 1990–1999 , 2001, Journal of epidemiology and community health.

[61]  A L Estrada,et al.  Drug use and HIV risks among African-American, Mexican-American, and Puerto Rican drug injectors. , 1998, Journal of psychoactive drugs.

[62]  R R Regal,et al.  Capture-recapture methods in epidemiology: methods and limitations. , 1995, Epidemiologic reviews.

[63]  A. Whiteside,et al.  The Hiv/aids Epidemic in Ukraine: Its Potential Social and Economic Impact Keywords: Hiv/aids Ukraine Socio-economic Impact Transition Potential 4 , 2022 .

[64]  P. Turnbull,et al.  "Just using old works": injecting risk behaviour in prison. , 1996, Drug and alcohol review.

[65]  M. Frischer,et al.  A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. , 2001, Addiction.

[66]  R. Coutinho,et al.  A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam , 1993, European Journal of Epidemiology.

[67]  D. Heckathorn,et al.  Extensions of Respondent-Driven Sampling: A New Approach to the Study of Injection Drug Users Aged 18–25 , 2002, AIDS and Behavior.